Starting Dose of Tegretol (Carbamazepine) for Acute Mania
For adults with acute mania, start carbamazepine at 200 mg twice daily (400 mg/day total), then increase by up to 200 mg/day at weekly intervals as tolerated, targeting 800-1200 mg/day for therapeutic effect. 1
Dosing Algorithm
Initial Dosing
- Start: 200 mg twice daily (400 mg/day total) using tablets or extended-release formulation 1
- Take with meals to improve tolerability 1
- For suspension formulation: 1 teaspoon (100 mg) four times daily, though this produces higher peak levels and may increase side effects 1
Titration Schedule
- Increase by 200 mg/day at weekly intervals until optimal response is achieved 1
- Target dose: 800-1200 mg/day for maintenance 1
- Maximum dose: 1600 mg/day (used rarely in adults) 1
- Monitor for neuromuscular and cognitive adverse effects during escalation, which necessitate the relatively slow titration 2
Important Timing Considerations
Carbamazepine requires slower dose escalation compared to other mood stabilizers like valproate (which can start at 20 mg/kg) or lithium (which can start at 15 mg/kg) due to tolerability concerns 2. This slower titration may delay therapeutic response compared to alternatives.
Clinical Context and Evidence Strength
Efficacy Evidence
Carbamazepine has demonstrated efficacy in acute mania through multiple large randomized controlled trials. Extended-release formulations showed significant improvement in Young Mania Rating Scale (YMRS) scores beginning at day 7, with response rates around 41.5% versus 22.4% for placebo 3, 4. However, carbamazepine is not a first-line agent for acute mania 5.
Position in Treatment Hierarchy
Guidelines classify carbamazepine as having "some support for efficacy in adult studies" but note it is not FDA-approved for bipolar disorder 5. First-line agents with FDA approval for acute mania include:
- Lithium (approved down to age 12)
- Atypical antipsychotics (aripiprazole, olanzapine, risperidone, quetiapine, ziprasidone)
- Valproate 5
Common Adverse Effects
Most frequent side effects during titration include:
These effects are dose-dependent and typically occur during the initial titration phase, reinforcing the need for gradual dose escalation.
Critical Considerations
Drug Interactions
Carbamazepine is a potent inducer of its own metabolism (autoinduction complete after 3-5 weeks) and cytochrome P450 3A4 1. This creates significant drug-drug interaction potential with:
- Other mood stabilizers
- Antipsychotics
- Oral contraceptives
- Many other medications metabolized by CYP3A4
Do not mix carbamazepine suspension with liquid chlorpromazine or thioridazine due to precipitate formation 1.
Monitoring Requirements
- Baseline and periodic blood levels (therapeutic range: 4-12 mcg/mL) 1
- Complete blood count (risk of blood dyscrasias)
- Liver function tests
- Electrolytes, particularly sodium (risk of hyponatremia)
- Lipid panel (carbamazepine increases total cholesterol, including both HDL and LDL) 3
When to Consider Carbamazepine
Use carbamazepine when:
- First-line agents have failed or are contraindicated
- Patient has history of positive response to carbamazepine
- Family history suggests carbamazepine response 5
- Treating rapid cycling or mixed episodes where some evidence suggests benefit 6
Extended-Release Formulation Advantages
Extended-release capsules (Tegretol-XR) can be dosed twice daily rather than 3-4 times daily, improving adherence. Once-daily dosing at bedtime has shown equivalent efficacy to twice-daily dosing in some studies 7, though twice-daily remains the standard FDA-labeled approach 1.